1. Letter to the Editor: Regarding “The Utility and Limitations of FRAX: A US Perspective”

   • Edward Czerwinski

   Letter to the Editor Open access 01 February 2012 Pages: 1 - 2

   

2. Reply to the Letter by E. Czerwinski Regarding “The Utility and Limitations of FRAX: A US Perspective”

   • Stuart L. Silverman
   • Andrew D. Calderon

   Letter to the Editor 17 January 2012 Pages: 3 - 3

3. Vitamin D in the New Millennium

   • Sunil J. Wimalawansa

   Current Therapeutics (SL Silverman, Section Editor) 17 January 2012 Pages: 4 - 15

   

4. Data from Extension Trials: Denosumab and Zoledronic Acid

   • Robin K. Dore

   Current Therapeutics (SL Silverman, Section Editor) 16 November 2011 Pages: 16 - 21

   

5. Secondary Fracture Prevention

   • Robert A. Adler

   Current Therapeutics (SL Silverman, Section Editor) 04 February 2012 Pages: 22 - 27

6. Assessment of Fracture Risk

   • Sanford Baim
   • William D. Leslie

   Current Therapeutics (SL Silverman, Section Editor) 26 January 2012 Pages: 28 - 41

   

7. Can PET-CT Imaging and Radiokinetic Analyses Provide Useful Clinical Information on Atypical Femoral Shaft Fracture in Osteoporotic Patients?

   • C. Haile Chesnut IV
   • Charles H. Chesnut III

   Current Therapeutics (SL Silverman, Section Editor) 29 January 2012 Pages: 42 - 47

8. Osteoporosis After Transplantation

   • Carolina A. Moreira Kulak
   • Victoria Z. Cochenski Borba
   • Melani Ribeiro Custódio

   Current Therapeutics (SL Silverman, Section Editor) 14 December 2011 Pages: 48 - 55

   

9. Clinical Use of Bone Turnover Markers to Monitor Pharmacologic Fracture Prevention Therapy

   • John T. Schousboe
   • Douglas C. Bauer

   Current Therapeutics (SL Silverman, Section Editor) 28 January 2012 Pages: 56 - 63

10. Sclerostin: Therapeutic Horizons Based Upon Its Actions

    • Aline G. Costa
    • John P. Bilezikian

    Future Therapeutics (P Miller, Section Editor) 11 January 2012 Pages: 64 - 72

    

11. Inhibition of Cathepsin K for Treatment of Osteoporosis

    • Steven Boonen
    • Elizabeth Rosenberg
    • Socrates Papapoulos

    Future Therapeutics (P Miller, Section Editor) 08 January 2012 Pages: 73 - 79

    

12. Oral Calcitonin

    • Michael J. Maricic

    Future Therapeutics (P Miller, Section Editor) 27 January 2012 Pages: 80 - 85

13. Nitric Oxide Donors for the Treatment of Osteoporosis

    • Sophie A. Jamal
    • Celeste J. Hamilton

    Future Therapeutics (P Miller, Section Editor) 31 December 2011 Pages: 86 - 92

    

14. Potential Role for Therapies Targeting DKK1, LRP5, and Serotonin in the Treatment of Osteoporosis

    • Wei Zhang
    • Matthew T. Drake

    Future Therapeutics (P Miller, Section Editor) 31 December 2011 Pages: 93 - 100